| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CLOVIS ONCOLOGY INC | 2,730,887 | 121,306,000 | 13.32% | ||
| 2 | HORIZON PHARMA PLC | 5,793,903 | 93,745,000 | 10.30% | ||
| 3 | UNITED THERAPEUTICS | 580,701 | 83,290,000 | 9.15% | ||
| 4 | AMARIN CORP PLC | 25,052,380 | 77,161,000 | 8.47% | ||
| 5 | MALLINCKRODT PUB LTD CO SHS | 1,153,944 | 57,489,000 | 6.31% | ||
| 6 | RETROPHIN INC COM | 2,772,156 | 52,477,000 | 5.76% | ||
| 7 | ATRICURE INC | 2,666,354 | 52,181,000 | 5.73% | ||
| 8 | GLOBUS MED INC | 1,860,000 | 46,165,000 | 5.07% | ||
| 9 | ARIAD PHARMACEUTICALS INC | 3,553,943 | 44,211,000 | 4.86% | ||
| 10 | MEDNAX INC | 660,000 | 43,996,000 | 4.83% | ||
| 11 | MYRIAD GENETICS INC | 2,328,932 | 38,823,000 | 4.26% | ||
| 12 | SANOFI SPOND FUNSPONSORED ADR | 9,067,998 | 36,997,000 | 4.06% | ||
| 13 | AMAG PHARMACEUTICALS INC COM | 1,026,902 | 35,736,000 | 3.92% | ||
| 14 | ANI PHARMACEUTICALS INC COM | 491,608 | 29,801,000 | 3.27% | ||
| 15 | ARRAY BIOPHARMA INC COM | 2,723,471 | 23,912,000 | 2.63% | ||
| 16 | PACIRA BIOSCIENCES INC | 631,805 | 20,407,000 | 2.24% | ||
| 17 | NOVADAQ TECHNOLOGIES INC | 2,413,179 | 17,109,000 | 1.88% | ||
| 18 | ACADIA HEALTHCARE COMPANY IN | 510,666 | 16,903,000 | 1.86% | ||
| 19 | VERICEL CORP | 2,982,940 | 8,949,000 | 0.98% | ||
| 20 | ADMA BIOLOGICS, INC. | 1,273,933 | 6,523,000 | 0.72% | ||
| 21 | BIOLASE INC | 1,449,022 | 2,029,000 | 0.22% | ||
| 22 | SEASPINE HLDGS CORP COM | 128,127 | 1,012,000 | 0.11% | ||
| 23 | VERACYTE INC | 46,752 | 362,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-17-000670, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
